🇺🇸 FDA
Pipeline program

C16G2 Varnish

C3J16-V204-00

Phase 2 small_molecule completed

Quick answer

C16G2 Varnish for Dental Caries is a Phase 2 program (small_molecule) at Armata Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Armata Pharmaceuticals
Indication
Dental Caries
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials